Pretreatment levels of the serum biomarkers CEA, CYFRA 21–1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 5
(1)
◽
pp. 38-42
Keyword(s):